혈액 처리 기기 및 소모품 시장 : 제품별, 최종 사용자별 - 세계 예측(2025-2030년)

The Blood Processing Devices & Consumables Market was valued at USD 46.18 billion in 2023, expected to reach USD 51.02 billion in 2024, and is projected to grow at a CAGR of 10.57%, to USD 93.35 billion by 2030.

The Blood Processing Devices & Consumables market encompasses an extensive range of products used in the collection, processing, storage, and management of blood and its components. This includes devices like centrifuges, blood bags, cell processors, and consumables such as blood filters and reagents. These tools are crucial in medical settings for transfusions, testing, and research, driving the necessity for advanced and efficient processing technologies. The market serves hospitals, diagnostic centers, blood banks, and research institutes, reflecting its broad application and end-use scope.

Key growth factors influencing the market include the rising prevalence of chronic diseases necessitating frequent blood tests and transfusions, advancements in blood processing technology, and increasing awareness about blood donations. Additionally, government initiatives and policies supporting healthcare infrastructure improvements further stimulate demand. However, challenges such as the high cost of automated devices, stringent regulatory requirements, and risks associated with blood transfusions may hinder market growth. Nonetheless, trends in developing cost-effective and user-friendly devices offer significant opportunities.

Recent developments highlight the potential of integrating machine learning and AI in blood processing to enhance efficiency and accuracy. Moreover, innovations in portable and point-of-care devices cater to remote healthcare needs and emergency settings. It is recommended for businesses to focus on sustainability by developing eco-friendly consumables and to invest in R&D to improve automation in blood processing devices, thereby expanding their market presence.

While navigating limitations such as budget constraints in healthcare facilities of developing regions, companies can tap into the untapped markets of Asia-Pacific and Africa, where healthcare infrastructure is on an upward trajectory. The nature of the market is competitive and rapidly evolving, necessitating continuous innovation and strategic partnerships. Engaging in collaboration with healthcare providers and policymakers can facilitate better market acceptance and adoption of advanced blood processing technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Processing Devices & Consumables Market

The Blood Processing Devices & Consumables Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of infectious diseases and contamination
  • Rise in number of blood donation awareness campaigns and blood banks
  • Growing adoption of blood processing devices & consumables in academic research institutes
• Market Restraints
  • Incidences related to blood processing devices & consumables recall
• Market Opportunities
  • Development and introduction of advanced blood processing devices & consumables
  • Growing research & development in cell therapies and regenerative medicine
• Market Challenges
  • Stringent regulatory and approval processes

Porter's Five Forces: A Strategic Tool for Navigating the Blood Processing Devices & Consumables Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Processing Devices & Consumables Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Processing Devices & Consumables Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Processing Devices & Consumables Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Processing Devices & Consumables Market

A detailed market share analysis in the Blood Processing Devices & Consumables Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Processing Devices & Consumables Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Processing Devices & Consumables Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Processing Devices & Consumables Market

A strategic analysis of the Blood Processing Devices & Consumables Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Processing Devices & Consumables Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advance Labs Scientific Pvt. Ltd., Azenta, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioMerieux SA, Boekel Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Immucor, Inc., Kiefel GmbH, Maco Pharma International GmbH, Nipro Corporation, Polymedicure, Terumo Corporation, Thermo Fisher Scientific, Inc., Thermogenesis Holdings, Inc., Troge Medical GmbH, Valtronic Technologies, and Vitrex Medical A/S.

Market Segmentation & Coverage

This research report categorizes the Blood Processing Devices & Consumables Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Blood Processing Consumables and Blood Processing Devices. The Blood Processing Consumables is further studied across Blood Administration Sets, Blood Bags, Blood Collection Needles, Blood Collection Tubes, Blood Filters, Blood Lancets, Coagulation Reagents, Hematology Reagents, Microscopic Slides, Sedimentation Tubes, Slide Stainers, Test Tube Racks, and Vials. The Blood Processing Devices is further studied across Blood Bank Freezers & Refrigerators, Blood Cell Processers, Blood Grouping Analyzers, Blood Warmer, and Hematocrit Centrifuges.
• Based on End User, market is studied across Academic Institutes, Blood Banks, Clinics, Diagnostic Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of infectious diseases and contamination
    • 5.1.1.2. Rise in number of blood donation awareness campaigns and blood banks
    • 5.1.1.3. Growing adoption of blood processing devices & consumables in academic research institutes
  • 5.1.2. Restraints
    • 5.1.2.1. Incidences related to blood processing devices & consumables recall
  • 5.1.3. Opportunities
    • 5.1.3.1. Development and introduction of advanced blood processing devices & consumables
    • 5.1.3.2. Growing research & development in cell therapies and regenerative medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory and approval processes
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Processing Devices & Consumables Market, by Product

• 6.1. Introduction
• 6.2. Blood Processing Consumables
  • 6.2.1. Blood Administration Sets
  • 6.2.2. Blood Bags
  • 6.2.3. Blood Collection Needles
  • 6.2.4. Blood Collection Tubes
  • 6.2.5. Blood Filters
  • 6.2.6. Blood Lancets
  • 6.2.7. Coagulation Reagents
  • 6.2.8. Hematology Reagents
  • 6.2.9. Microscopic Slides
  • 6.2.10. Sedimentation Tubes
  • 6.2.11. Slide Stainers
  • 6.2.12. Test Tube Racks
  • 6.2.13. Vials
• 6.3. Blood Processing Devices
  • 6.3.1. Blood Bank Freezers & Refrigerators
  • 6.3.2. Blood Cell Processers
  • 6.3.3. Blood Grouping Analyzers
  • 6.3.4. Blood Warmer
  • 6.3.5. Hematocrit Centrifuges

7. Blood Processing Devices & Consumables Market, by End User

• 7.1. Introduction
• 7.2. Academic Institutes
• 7.3. Blood Banks
• 7.4. Clinics
• 7.5. Diagnostic Centers
• 7.6. Hospitals

8. Americas Blood Processing Devices & Consumables Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Blood Processing Devices & Consumables Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Blood Processing Devices & Consumables Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Advance Labs Scientific Pvt. Ltd.
• 3. Azenta, Inc.
• 4. Beckman Coulter, Inc.
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. BioMerieux SA
• 8. Boekel Scientific
• 9. Danaher Corporation
• 10. F. Hoffmann-La Roche Ltd.
• 11. Fresenius SE & Co. KGaA
• 12. Grifols, S.A.
• 13. Haemonetics Corporation
• 14. Immucor, Inc.
• 15. Kiefel GmbH
• 16. Maco Pharma International GmbH
• 17. Nipro Corporation
• 18. Polymedicure
• 19. Terumo Corporation
• 20. Thermo Fisher Scientific, Inc.
• 21. Thermogenesis Holdings, Inc.
• 22. Troge Medical GmbH
• 23. Valtronic Technologies
• 24. Vitrex Medical A/S